Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis

by Ann Chai, L.Y., Kullberg, B.J., Earnest, A., Johnson, E.M., Teerenstra, S., Vonk, A.G., Schlamm, H.T., Herbrecht, R., Netea, M.G., Troke, P.F.
Published 2014